My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 261

    1.

    Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.

    Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG.

    Diabetes. 2002 Oct;51(10):3020-4.PMID: 12351442 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.

    Søndergaard HM, Bøttcher M, Marie Madsen M, Schmitz O, Hansen SB, Nielsen TT, Bøtker HE.

    J Clin Endocrinol Metab. 2006 Dec;91(12):4854-61. Epub 2006 Sep 19.PMID: 16984986 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

    Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E.

    J Clin Invest. 1996 Nov 1;98(9):2094-9.PMID: 8903329 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.

    Yokoyama I, Ohtake T, Momomura S, Yonekura K, Yamada N, Nishikawa J, Sasaki Y, Omata M.

    J Nucl Med. 1998 May;39(5):884-9.PMID: 9591594 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus.

    Yokoyama I, Yonekura K, Ohtake T, Kawamura H, Matsumoto A, Inoue Y, Aoyagi T, Sugiura S, Omata M, Ohtomo K, Nagai R.

    J Nucl Cardiol. 2000 May-Jun;7(3):242-8.PMID: 10888395 [PubMed - indexed for MEDLINE]Related articles

    6.

    Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P.

    J Clin Endocrinol Metab. 2003 May;88(5):2055-60.PMID: 12727954 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.

    Williams KV, Bertoldo A, Kinahan P, Cobelli C, Kelley DE.

    Diabetes. 2003 Jul;52(7):1619-26.PMID: 12829624 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.

    Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS.

    J Nucl Med. 2001 Dec;42(12):1730-6.PMID: 11752067 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.

    Mäki M, Nuutila P, Laine H, Voipio-Pulkki LM, Haaparanta M, Solin O, Knuuti JM.

    Diabetes. 1997 Sep;46(9):1491-6.PMID: 9287051 [PubMed - indexed for MEDLINE]Related articles

    10.

    Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin-resistant skeletal muscle of patients with type 1 diabetes.

    Peltoniemi P, Yki-Järvinen H, Oikonen V, Oksanen A, Takala TO, Rönnemaa T, Erkinjuntti M, Knuuti MJ, Nuutila P.

    Diabetes. 2001 Jun;50(6):1371-7.PMID: 11375338 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.

    Utriainen T, Takala T, Luotolahti M, Rönnemaa T, Laine H, Ruotsalainen U, Haaparanta M, Nuutila P, Yki-Järvinen H.

    Diabetologia. 1998 May;41(5):555-9.PMID: 9628273 [PubMed - indexed for MEDLINE]Related articles

    12.

    Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography.

    Nuutila P, Raitakari M, Laine H, Kirvelä O, Takala T, Utriainen T, Mäkimattila S, Pitkänen OP, Ruotsalainen U, Iida H, Knuuti J, Yki-Järvinen H.

    J Clin Invest. 1996 Apr 1;97(7):1741-7.PMID: 8601640 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.

    Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teräs M, Bergman J, Haaparanta M, Voipio-Pulkki LM, Viikari J, et al.

    Am J Physiol. 1993 May;264(5 Pt 1):E756-62.PMID: 8498497 [PubMed - indexed for MEDLINE]Related articles

    14.

    Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers.

    Rönnemaa EM, Rönnemaa T, Utriainen T, Raitakari M, Laine H, Takala T, Pitkänen OP, Kirvelä O, Knuuti J, Nuutila P.

    Metabolism. 1999 Feb;48(2):239-44.PMID: 10024089 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of insulin on blood flow and volume in skeletal muscle of patients with IDDM: studies using [15O]H2O, [15O]CO, and positron emission tomography.

    Raitakari M, Nuutila P, Knuuti J, Raitakari OT, Laine H, Ruotsalainen U, Kirvelä O, Takala TO, Iida H, Yki-Järvinen H.

    Diabetes. 1997 Dec;46(12):2017-21.PMID: 9392489 [PubMed - indexed for MEDLINE]Related articles

    16.

    Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography.

    Nuutila P, Peltoniemi P, Oikonen V, Larmola K, Kemppainen J, Takala T, Sipilä H, Oksanen A, Ruotsalainen U, Bolli GB, Yki-Järvinen H.

    Diabetes. 2000 Jul;49(7):1084-91.PMID: 10909962 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study.

    Lautamäki R, Airaksinen KE, Seppänen M, Toikka J, Luotolahti M, Ball E, Borra R, Härkönen R, Iozzo P, Stewart M, Knuuti J, Nuutila P.

    Diabetes. 2005 Sep;54(9):2787-94.PMID: 16123370 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.

    Yokoyama I, Yonekura K, Moritan T, Tateno M, Momose T, Ohtomo K, Inoue Y, Nagai R.

    J Nucl Med. 2001 Jul;42(7):1005-10.PMID: 11438619 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin resistance in patients with cardiac hypertrophy.

    Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG.

    Cardiovasc Res. 1999 Apr;42(1):246-53.PMID: 10435017 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evidence for spatial heterogeneity in insulin- and exercise-induced increases in glucose uptake: studies in normal subjects and patients with type 1 diabetes.

    Peltoniemi P, Yki-Järvinen H, Laine H, Oikonen V, Rönnemaa T, Kalliokoski K, Raitakari O, Knuuti MJ, Nuutila P.

    J Clin Endocrinol Metab. 2001 Nov;86(11):5525-33.PMID: 11701731 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity